Pneumonia prevention: Cost-effectiveness analyses of two vaccines among refugee children aged under two years, Haemophilus influenzae type b-containing and pneumococcal conjugate vaccines, during a humanitarian emergency, Yida camp, South Sudan
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Pneumonia Prevention during a Humanitarian Emergency: Cost-effectiveness of Haemophilus Influenzae Type B Conjugate Vaccine and Pneumococcal Conjugate Vaccine in SomaliaPrehospital and Disaster Medicine, 2015
- Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010The Lancet, 2012
- Cost-effectiveness of Haemophilus influenzae type b (Hib) vaccine introduction in the universal immunization schedule in Haryana State, IndiaHealth Policy and Planning, 2012
- Cost effectiveness of child pneumococcal conjugate vaccination in GAVI-eligible countriesInternational Health, 2011
- Measles vaccination in humanitarian emergencies: a review of recent practiceConflict and Health, 2011
- Projected health benefits and costs of pneumococcal and rotavirus vaccination in UgandaVaccine, 2011
- Global, regional, and national causes of child mortality in 2008: a systematic analysisThe Lancet, 2010
- Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimatesThe Lancet, 2009
- Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trialThe Lancet, 2005
- Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infantsThe Lancet, 1997